Ever Source Wealth Advisors, LLC Ligand Pharmaceuticals Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 44 shares of LGND stock, worth $4,817. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44
Previous 32
37.5%
Holding current value
$4,817
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LGND
# of Institutions
280Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$314 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$225 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$112 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$99.2 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$81.6 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.85B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...